ESC Premium Access

Drug treatment of acute coronary syndrome patients

Event: ESC CONGRESS 2017
Topic: Adjunctive medical therapy
Session type: Rapid Fire Abstracts
Date: 28 August 2017
Time: 11:00 - 12:30

Session

9 presentations in this session

New use of low-dose aspirin and risk of intracerebral haemorrhage, subdural haematoma and subarachnoid haemorrhage: associations by sex, case-fatality and trauma status in a large observational study.

Speaker: Doctor L. Garcia Rodriguez (Madrid, ES)
Thumbnail

Antiplatelet effects of oral P2Y12-receptor inhibitor loading strategies for transitioning from cangrelor

Speaker: Assistant Professor W. Hochholzer (Bad Krozingen, DE)
Thumbnail

G-CSF effects on left ventricular function assessed with standard echocardiographic evaluation (biplane EF) and 2D myocardial strain in patients with STEMI and LV dysfunction

Speaker: Doctor S. Righetti (Monza, IT)
Thumbnail

Ticagrelor improves cardiac function and post-myocardial infarction healing: cardiac magnetic resonance imaging assessment of functional, anatomical and remodeling parameters.

Speaker: Doctor G. Mendieta Badimon (Madrid, ES)
Thumbnail

Genetic variability in PAR4 platelet response in relation to bleeding and ischemic outcomes: a genetic substudy of the TRACER trial.

Speaker: Doctor P. Tricoci (Durham, US)
Thumbnail

Effectiveness and safety of ticagrelor compared with clopidogrel and prasugrel: results from a cohort study in the nationwide french claims and hospitalisation database (SNIIRAM)

Speaker: Professor N. Danchin (Paris, FR)
Thumbnail

Is aspirin needed after Takotsubo syndrome?: a propensity score sub-analysis of inter-tak registry

Speaker: Doctor F. D'Ascenzo (Turin, IT)
Thumbnail

Does ticagrelor decrease the risk of recurrent fatal or non-fatal myocardial infarction in real-world settings? The AReMIS case-cohort study

Speaker: Professor N. Danchin (Paris, FR)
Thumbnail

Hypothermia impairs platelet-function in resuscitated patients after myocardial infarction

Speaker: Associate Professor D. von Lewinski (Graz, AT)
Thumbnail

9 speakers from this session

Doctor Luis Alberto Garcia Rodriguez

Centro Español de Investigación Farmacoepidemiológica (CEIFE), Madrid (Spain)
0 follower

Assistant Professor Willibald Hochholzer

University Heart Center Freiburg-Bad Krozingen, Bad Krozingen (Germany)
0 follower

Doctor Stefano Righetti

San Gerardo Vecchio Hospital, Monza (Italy)
0 follower

Doctor Guiomar Mendieta Badimon

National Centre for Cardiovascular Research (CNIC), Madrid (Spain)
0 follower

Doctor Pierluigi Tricoci

Duke University Medical Center, Duke Clinical Research Institute, Durham (United States of America)
3 presentations
0 follower

Professor Nicolas Danchin

AP-HP - European Hospital Georges Pompidou, Paris (France)
13 presentations
0 follower

Doctor Fabrizio D'Ascenzo

Hospital Molinette of the University Hospital S. Giovanni Battista, Turin (Italy)
1 presentation
0 follower

Professor Nicolas Danchin

AP-HP - European Hospital Georges Pompidou, Paris (France)
13 presentations
0 follower

Associate Professor Dirk von Lewinski

Medical University of Graz, Graz (Austria)
4 presentations
0 follower

This platform is supported by

logo Novo Nordisk